A detailed history of Isthmus Partners, LLC transactions in Cabot Corp stock. As of the latest transaction made, Isthmus Partners, LLC holds 3,885 shares of CBT stock, worth $422,726. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,885
Previous 3,446 12.74%
Holding current value
$422,726
Previous $316,000 37.34%
% of portfolio
0.05%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$86.96 - $111.73 $38,175 - $49,049
439 Added 12.74%
3,885 $434,000
Q2 2024

Aug 06, 2024

BUY
$90.69 - $102.77 $14,329 - $16,237
158 Added 4.81%
3,446 $316,000
Q4 2023

Feb 12, 2024

BUY
$65.66 - $86.28 $215,890 - $283,688
3,288 New
3,288 $274,000

Others Institutions Holding CBT

About CABOT CORP


  • Ticker CBT
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 56,299,200
  • Market Cap $6.13B
  • Description
  • Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such...
More about CBT
Track This Portfolio

Track Isthmus Partners, LLC Portfolio

Follow Isthmus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Isthmus Partners, LLC with notifications on news.